Shanghai, China

Chenghao Xi

This inventor holds 2 USPTO granted patents. Top assignees: Shanghai Synergy Pharmaceutical Sciences Co., Ltd., Shanghai Synergy Pharmaceutical Sciences, Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chenghao Xi. Retrieved from https://idiyas.com/inventor/chenghao-xi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Chenghao Xi

Introduction

Chenghao Xi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on JAK kinase inhibitors. His research focuses on developing novel compounds that can improve efficacy and safety in treating JAK-related conditions.

Latest Patents

Chenghao Xi holds 1 patent for his invention titled "JAK kinase inhibitor, preparation method for same, and applications thereof in the field of medicine." This patent describes a novel small molecule JAK inhibitor, which is designed to provide enhanced therapeutic benefits in preventing or treating JAK-related indications.

Career Highlights

Throughout his career, Chenghao Xi has worked with notable companies such as Shanghai Synergy Pharmaceutical Sciences Co., Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of effective medicinal therapies.

Collaborations

Chenghao Xi has collaborated with talented individuals in his field, including coworkers Xin Xu and Jia Chen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Chenghao Xi's work in the field of medicinal chemistry, particularly with JAK kinase inhibitors, showcases his dedication to advancing medical science. His contributions are paving the way for improved treatments and better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…